Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.38 AUD | -5.95% | -4.77% | -10.12% |
Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
Mar. 14 | Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16 | MT |
Sales 2024 * | 89.47M 57.4M | Sales 2025 * | 101M 64.97M | Capitalization | 721M 462M |
---|---|---|---|---|---|
Net income 2024 * | 34M 21.81M | Net income 2025 * | 37M 23.74M | EV / Sales 2024 * | 5.97 x |
Net cash position 2024 * | 187M 120M | Net cash position 2025 * | 216M 138M | EV / Sales 2025 * | 4.99 x |
P/E ratio 2024 * |
21.1
x | P/E ratio 2025 * |
19.4
x | Employees | - |
Yield 2024 * |
0.47% | Yield 2025 * |
0.51% | Free-Float | 79.56% |
Latest transcript on Clinuvel Pharmaceuticals Limited
1 day | -5.95% | ||
1 week | -4.77% | ||
Current month | +0.14% | ||
1 month | +4.43% | ||
3 months | -7.82% | ||
6 months | -9.73% | ||
Current year | -10.12% |
Managers | Title | Age | Since |
---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 61 | 05-10-31 |
Darren M. Keamy
DFI | Director of Finance/CFO | - | 05-10-31 |
Lachlan Hay
COO | Chief Operating Officer | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 61 | 05-10-31 |
Director/Board Member | - | 07-02-05 | |
Karen Agersborg
BRD | Director/Board Member | - | 18-01-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 14.38 | -5.95% | 254,065 |
24-04-18 | 15.29 | +0.92% | 62,525 |
24-04-17 | 15.15 | 0.00% | 58,904 |
24-04-16 | 15.15 | -0.33% | 74,156 |
24-04-15 | 15.2 | +0.66% | 77,148 |
Delayed Quote Australian S.E., April 19, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.12% | 463M | |
-5.99% | 83.66B | |
+2.76% | 40.41B | |
-24.88% | 28.26B | |
+53.61% | 24.53B | |
-8.08% | 16.82B | |
-33.74% | 13.39B | |
-16.63% | 11.75B | |
-11.19% | 11.69B | |
-2.25% | 8.13B |
- Stock Market
- Equities
- CUV Stock